Burden of hair loss: stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia.

Hair loss, as it occurs with telogen effluvium and androgenetic alopecia, provokes anxieties and distress more profound than its objective severity would appear to justify. This reflects the profound symbolic and psychosocial importance of hair. Stress has long been implicated as one of the causal factors involved in hair loss. Recently, in vivo studies in mice have substantiated the long-held popular belief that stress can exert profound hair growth-inhibitory catagen-inducing and hair-damaging pro-inflammatory effects. Insights into the negative impact of stress on hair growth and the integration of stress-coping strategies into the management of hair loss disorders as well as the development of new pharmacotherapeutic strategies might lead to enhanced therapeutic modalities with the alleviation of clinical symptoms as well as the concomitant psychological implications.

[1]  B. Klapp,et al.  Neurogenic inflammation in stress-induced termination of murine hair growth is promoted by nerve growth factor. , 2004, The American journal of pathology.

[2]  B. Klapp,et al.  Topical minoxidil counteracts stress‐induced hair growth inhibition in mice , 2003, Experimental dermatology.

[3]  S. Kawana,et al.  Intermittent foot shock stress prolongs the telogen stage in the hair cycle of mice , 2003, Experimental dermatology.

[4]  V. Botchkarev.  Stress and the hair follicle: exploring the connections. , 2003, The American journal of pathology.

[5]  B. Klapp,et al.  Stress inhibits hair growth in mice by induction of premature catagen development and deleterious perifollicular inflammatory events via neuropeptide substance P-dependent pathways. , 2003, The American journal of pathology.

[6]  G. Panfilis.  'Activation-induced cell death': a special program able to preserve the homeostasis of the skin? , 2002 .

[7]  B. Klapp,et al.  Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[8]  R. Paus.  Stress and the skin , 2001, Experimental dermatology.

[9]  M. Chren,et al.  Strategies of coping and quality of life in women with alopecia , 2001, The British journal of dermatology.

[10]  T. F. Cash,et al.  The psychology of hair loss and its implications for patient care. , 2001, Clinics in dermatology.

[11]  R. Paus,et al.  High‐dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo , 2000, The British journal of dermatology.

[12]  R. Paus.  Stress, Hair Growth Control, and the Neuro-Endocrine-Immune Connection , 2000 .

[13]  R. Paus,et al.  Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. , 2000, Physiological reviews.

[14]  M S Kramer,et al.  Discovery of the antidepressant and anti-emetic efficacy of substance P receptor (NK1) antagonists. , 1999, Trends in pharmacological sciences.

[15]  R. Paus,et al.  Cutaneous Expression of CRH and CRH‐R: Is There a “Skin Stress Response System?” , 1999, Annals of the New York Academy of Sciences.

[16]  R Paus,et al.  The biology of hair follicles. , 1999, The New England journal of medicine.

[17]  C. Stratakis,et al.  Neuroendocrinology and Pathophysiology of the Stress System , 1995, Annals of the New York Academy of Sciences.

[18]  A. Buhl.  Minoxidil's action in hair follicles. , 1991, The Journal of investigative dermatology.

[19]  J. Passchier,et al.  Psychological problems with hair loss in general practice and the treatment policies of general practitioners. , 1990 .

[20]  T. Kawabe,et al.  Minoxidil stimulates mouse vibrissae follicles in organ culture. , 1989, The Journal of investigative dermatology.